| Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy X Li, MT Lewis, J Huang, C Gutierrez, CK Osborne, MF Wu, ... Journal of the National Cancer Institute 100 (9), 672-679, 2008 | 2220 | 2008 |
| Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features CJ Creighton, X Li, M Landis, JM Dixon, VM Neumeister, A Sjolund, ... Proceedings of the National Academy of Sciences 106 (33), 13820-13825, 2009 | 1638 | 2009 |
| Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming L Tian, A Goldstein, H Wang, H Ching Lo, IK Sun Kim, T Welte, K Sheng, ... Nature 544 (7649), 250-254, 2017 | 685 | 2017 |
| A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models X Zhang, S Claerhout, A Prat, LE Dobrolecki, I Petrovic, Q Lai, MD Landis, ... Cancer research 73 (15), 4885-4897, 2013 | 530 | 2013 |
| Patient-derived xenograft models of breast cancer and their predictive power JR Whittle, MT Lewis, GJ Lindeman, JE Visvader Breast cancer research 17, 1-13, 2015 | 329 | 2015 |
| Fatty acid oxidation-driven Src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast cancer JH Park, S Vithayathil, S Kumar, PL Sung, LE Dobrolecki, V Putluri, ... Cell reports 14 (9), 2154-2165, 2016 | 303 | 2016 |
| Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an … HJ Kim, BC Litzenburger, X Cui, DA Delgado, BC Grabiner, X Lin, ... Molecular and cellular biology 27 (8), 3165-3175, 2007 | 293 | 2007 |
| Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors AF Schott, MD Landis, G Dontu, KA Griffith, RM Layman, I Krop, ... Clinical Cancer Research 19 (6), 1512-1524, 2013 | 276 | 2013 |
| Patient-derived xenograft (PDX) models in basic and translational breast cancer research LE Dobrolecki, SD Airhart, DG Alferez, S Aparicio, F Behbod, ... Cancer and Metastasis Reviews 35, 547-573, 2016 | 275 | 2016 |
| A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster gene, bcr. D Ron, M Zannini, M Lewis, RB Wickner, LT Hunt, G Graziani, SR Tronick, ... The New Biologist 3 (4), 372-379, 1991 | 265 | 1991 |
| Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients JC Chang, EC Wooten, A Tsimelzon, SG Hilsenbeck, MC Gutierrez, ... Journal of Clinical Oncology 23 (6), 1169-1177, 2005 | 249 | 2005 |
| Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells F De Amicis, J Thirugnansampanthan, Y Cui, J Selever, A Beyer, I Parra, ... Breast cancer research and treatment 121, 1-11, 2010 | 242 | 2010 |
| A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology KP Guillen, M Fujita, AJ Butterfield, SD Scherer, MH Bailey, Z Chu, ... Nature cancer 3 (2), 232-250, 2022 | 222 | 2022 |
| Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia RC Moraes, X Zhang, N Harrington, JY Fung, MF Wu, SG Hilsenbeck, ... Oxford University Press for The Company of Biologists Limited 134 (6), 1231-1242, 2007 | 222 | 2007 |
| Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation T Welte, IS Kim, L Tian, X Gao, H Wang, J Li, XB Holdman, ... Nature cell biology 18 (6), 632-644, 2016 | 206 | 2016 |
| Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells AH Klopp, L Lacerda, A Gupta, BG Debeb, T Solley, L Li, E Spaeth, W Xu, ... PloS one 5 (8), e12180, 2010 | 204 | 2010 |
| Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer NA Zhao, J Cao, L Xu, Q Tang, LE Dobrolecki, X Lv, M Talukdar, Y Lu, ... The Journal of clinical investigation 128 (4), 1283-1299, 2018 | 194 | 2018 |
| The terminal end bud: the little engine that could IS Paine, MT Lewis Journal of mammary gland biology and neoplasia 22, 93-108, 2017 | 194 | 2017 |
| Membrane-localized estrogen receptor α is required for normal organ development and function A Pedram, M Razandi, M Lewis, S Hammes, ER Levin Developmental cell 29 (4), 482-490, 2014 | 191 | 2014 |
| Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer T Risom, EM Langer, MP Chapman, J Rantala, AJ Fields, C Boniface, ... Nature communications 9 (1), 1-17, 2018 | 171 | 2018 |
Susan HilsenbeckBaylor College of Medicine在 bcm.edu 的电子邮件经过验证